Search - tctmd.com

Displaying 321 - 340 of 404

Sort: Relevancy | Date

News Daily News

登记数据显示 LAA 封堵术的保护作用长达 2 年

Caitlin E. Cox

January 28, 2015

News Daily News

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Caitlin E. Cox

January 28, 2015

News Daily News

Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI

Caitlin E. Cox

January 28, 2015

News Daily News

Hospital Volume Linked to More Favorable LAA Closure Outcomes

Todd Neale

December 11, 2014

News Daily News

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Caitlin E. Cox

November 19, 2014

News Daily News

对房颤患者使用Amplatzer进行LAA封堵显得安全、有效

Yael L. Maxwell

November 06, 2014

News Daily News

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Yael L. Maxwell

November 06, 2014

News Daily News

El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA

Yael L. Maxwell

November 06, 2014

News Daily News

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

October 17, 2014

News Daily News

得到的FDA专家组支持率低，Watchman可能为时不多了

L.A. McKeown

October 16, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

News Industry News

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

October 08, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Daily News

研究发现，应当仅对风险最高的患者使用勒除器进行LAA封堵

Yael L. Maxwell

August 07, 2014

News Daily News

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Yael L. Maxwell

August 07, 2014

News Daily News

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

Yael L. Maxwell

August 07, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

Advertisement

登记数据显示 LAA 封堵术的保护作用长达 2 年

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI

Hospital Volume Linked to More Favorable LAA Closure Outcomes

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

对房颤患者使用Amplatzer进行LAA封堵显得安全、有效

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

得到的FDA专家组支持率低，Watchman可能为时不多了

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

研究发现，应当仅对风险最高的患者使用勒除器进行LAA封堵

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content